NL0010273215 (NL0010273215)

$1394.00
+0.66%
$533.7B
Market Cap
53.5
P/E Ratio
1.37
Beta
0.78%
Dividend Yield
Piotroski 8/9Altman Z 11.6 SafeBeneish M -2.84 CleanROIC−WACC +21.4%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 8/9, Altman Z 11.6 (above 3.0 safe zone threshold). DCF fair value of $688 implies 45% downside based on model assumptions.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency is exceptionally robust, evidenced by a return on invested capital of 34.6% that significantly outpaces the weighted average cost of capital at 13.2%, generating a spread of +21.4%. This high ROIC is primarily driven by superior operational leverage rather than financial engineering or margin compression, as indicated by strong profitability metrics including net margins of 29.4% and gross margins near 53%. The firm's fundamental stability is further corroborated by an Altman Z-Score of 11.6, signaling negligible bankruptcy risk, while a Piotroski F-Score of 8/9 reflects consistent financial strength with only minor deterioration in quality over the assessment period. Additionally, the Beneish M-Score of -2.84 suggests earnings are highly credible and unlikely to be manipulated by management.

Despite these operational strengths, current valuation metrics indicate significant compression relative to historical norms and intrinsic value models. The stock trades at a forward P/E of 51.3x, which represents a 70% premium over its five-year average of 30.1x, suggesting the market is pricing in aggressive future expansion rather than current earnings power. This valuation disconnect is reinforced by discounted cash flow analysis, which implies fair value at $688 and identifies an upside potential of -45.4%, indicating a substantial discount to the price paid for anticipated free cash flow growth rates averaging 24.5% over the next decade. The market appears willing to sustain this premium only if revenue can continue expanding at 15.6% year-over-year without margin erosion.

Risk-adjusted performance data reveals a nuanced picture where high absolute returns coexist with specific factor exposures that may limit long-term compounding potential under certain regime shifts. While the Fama-French alpha of 14.56% annually demonstrates strong stock-specific outperformance, this comes at the cost of significant exposure to growth factors, highlighted by a value factor (HML) of -0.321. This negative tilt suggests vulnerability if market conditions rotate toward value-oriented assets or if growth expectations normalize. Conversely, the profitability factor score remains neutral at 0.034, indicating that while high-quality earnings are present, they do not currently provide an additional premium in multi-factor models beyond what is already captured by valuation and alpha metrics.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive
Market Price
$1394.00
Fair Value
$700
Implied Upside
-49.8%
$700IMPLIED FAIR VALUEOVERVALUEDOVERUNDER
Growth Rate (Y1–5)25%
-10%20%50%
Discount Rate (WACC)13.2%
5%12.5%20%

5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.

Reverse DCFMarket-Implied
24.5%annual FCF growth priced in at $1394.00

The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 16% YoY revenue.

Sensitivity Matrix

TG ↓ / WACC →11.2%13.2%15.2%
2%$792$642$537
3%$867$688$568
4%$962$743$603

Center = base case. Green = >10% upside, Red = >10% downside vs $1394.00.

Pre-computed DCF: WACC=13.2%, terminal growth 3%. Fair value $688 (-45.4%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

8/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
11.6
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.84
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

52.8%
Gross Margin
29.4%
Net Margin
34.6%
ROIC
13.2%
WACC
ROIC − WACC Spread: +21.4%— Positive value creation spread.
+15.6%
Revenue Growth (YoY)
+26.9%
Earnings Growth (YoY)
11.0B
Free Cash Flow
23%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

1.58x
Debt / Equity
1.26x
Current Ratio
97.4x
Interest Coverage
-0.8x
Net Debt / EBITDA
2.28%
FCF Yield
12.6B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $5.79
Act: $6.00
+3.7%
Q3
✓ Beat
Est: $5.25
Act: $5.90
+12.4%
Q2
✓ Beat
Est: $5.37
Act: $5.49
+2.1%
Q1
✗ Miss
Est: $7.55
Act: $7.34
-2.7%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Dividend History

$2.7000
Latest Dividend
$6.56
2025 Total
+5.1%
YoY Growth
2 yrs
Consecutive Increases
Annual Dividends per Share
$2.65
2007
$0.28
2008
$0.26
2009
$0.22
2010
$0.44
2011
$0.60
2012
$0.53
2013
$0.61
2014
$0.70
2015
$1.05
2016
$1.20
2017
$1.40
2018
$3.15
2019
$2.55
2020
$3.35
2021
$6.44
2022
$5.96
2023
$6.24
2024
$6.56
2025
$4.30
2026
DateAmountChange
2026-04-24$2.7000+68.8%
2026-02-09$1.60000.0%
2025-10-28$1.60000.0%
2025-07-28$1.6000-13.0%
2025-04-25$1.8400+21.1%
2025-02-10$1.52000.0%
2024-10-29$1.52000.0%
2024-07-29$1.5200-13.1%
2024-04-26$1.7500+20.7%
2024-02-05$1.45000.0%
2023-11-01$1.45000.0%
2023-08-01$1.4500-14.2%
Stock Splits
2012-11-26: 0.77:12007-10-01: 0.888889:12000-04-17: 3:1

Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.

Risk Profile

38.0%
Annual Volatility
2.07
Sharpe (1Y)
0.80
Sharpe (3Y)
-44.8%
Max Drawdown (3Y)
-47.9%
Max Drawdown (5Y)

Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fama-French 5-Factor Exposure

Academic factor model decomposition — what's really driving this stock's returns.

0.74
Market β
Mkt-RF
-0.036
Size (SMB)
Neutral
-0.321
Value (HML)
Growth tilt
+0.034
Profit (RMW)
Neutral
-0.332
Invest (CMA)
Aggressive
Alpha (annual): +14.56%
R²: 13.5%of variance explained by 5 factors

Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.

Fundamentals

33.8
Forward P/E
2.40
PEG Ratio
25.62
Price/Book
736520
Avg Volume
$1437.00
52W High
$587.80
52W Low
95%
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$7.6B
Tracked Passive Exposure
6
ETFs Holding NL0010273215
1.98%
Avg Weight in ETFs
$385B
Total ETF AUM

When investors buy or sell ETFs like EFA or IEFA, the fund manager is mechanically forced to buy or sell NL0010273215 shares regardless of NL0010273215's individual fundamentals. We estimate $7.6B of passive capital is structurally linked to NL0010273215 through 6 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in NL0010273215 to visualize passive redemption contagion across ETFs and collateral stocks.

NL0010273215 Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
NL0010273215EpicenterIEFAETFEFAETFSCHFETFCH0012032048Low RiskNVDALow RiskCH0012005267Low RiskAAPLLow RiskGB0005405286High Risk
NL0010273215 Price Drop (%)0

If NL0010273215 (NL0010273215) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Roche Holding AG (CH0012032048) as the most exposed collateral stock, sharing 5 ETFs with NL0010273215. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

NL0010273215 Ownership Dynamics

Passive funds hold 1 in every 70 NL0010273215 shares, reducing daily market volatility.

Ticker
NL0010273215
Total Shares
385M
ETF Lock-Up
1.4%
Display Mode
Total Float Impact
1.4%Locked Float

NL0010273215 (NL0010273215) exerts measurable gravity on the passive index market, currently representing 2.6% of the iShares MSCI EAFE ETF (EFA) and 2.2% of the iShares Core MSCI EAFE ETF (IEFA). Across 6 tracked ETFs, approximately 6M shares (1.4% of float) are held by passive funds and rarely trade on the open market. As passive ownership grows, index inclusion changes may increasingly drive price discovery.

Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

NL0010273215 Institutional Volume Profile

252-day volume distribution by price level. The Point of Control (POC) marks the price where the most institutional volume transacted — an implicit support/resistance floor.

TICKER
NL0010273215
PRICE
$1394.00
FLOOR (POC)
$649.81
STRENGTH
High
$6077%$650POC 13%$6927%$735$777$820$8637%$90510%$948$990$1033$1075$1118$11609%$120313%$12466%$1288$1331$1373$1394.00$1416
Focus Zone
Point of Control (POC) Support (below price) Resistance (above price) Current Price

The highest-volume price zone for NL0010273215 over the past year sits near $649.81 (13% of 252-day volume). The current price of $1394.00 trades 114.5% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (13% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.

Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.

NL0010273215 Capital Efficiency

How efficiently does NL0010273215 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$11.0B
EBITDA
$12.6B
FCF Conversion
88%
Reinvestment Rate
12%
88% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
34.6%
ROIC − WACC Spread
21.4%

NL0010273215 converts 88% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 21.4% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Price Correlations

Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.

Peer252-Day (1Y)126-Day (6M)Direction
WTGXXNaNNaN
USN0705921000.6910.830Moderate
ASML0.6910.830Moderate
CH00122217160.6040.661Moderate
LRCX0.5120.654Moderate
AMAT0.5090.659Moderate
KLAC0.4800.591Moderate
TSM0.4560.590Moderate
MU0.3770.469Moderate
GLW0.3660.508Moderate

Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.

Compare NL0010273215 to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-01.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.